David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 35.73% |
| 2 | Technology | 18.6% |
| 3 | Consumer Discretionary | 9.12% |
| 4 | Healthcare | 7.62% |
| 5 | Industrials | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLXY
2801
Galaxy Digital Inc
GLXY
$5B
| $2.4M | ﹤0.01% |
107,193
-7,207
| -6% | -$223K |
|
2802
CALL
Forward Air
FWRD
$595M
| $2.4M | ﹤0.01% |
95,800
-700
| -0.7% | -$15.8K |
|
2803
CryoPort
CYRX
$839M
| $2.39M | ﹤0.01% |
249,303
-137,492
| -36% | -$1.3M |
|
2804
CALL
Union Pacific
UNP
$183B
| $2.38M | ﹤0.01% |
10,300
-208,300
| -95% | -$47.5M |
|
2805
Phibro Animal Health
PAHC
$1.47B
| $2.38M | ﹤0.01% |
63,574
-31,098
| -33% | -$1.26M |
|
|
ABVX
2806
Abivax
ABVX
$10.2B
| $2.37M | ﹤0.01% |
17,600
-9,937
| -36% | -$1.08M |
|
|
LOVE
2807
LoveSac
LOVE
$240M
| $2.37M | ﹤0.01% |
160,804
+79,360
| +97% | +$1.12M |
|
2808
Broadstone Net Lease
BNL
$4.34B
| $2.36M | ﹤0.01% |
135,893
+90,052
| +196% | +$1.62M |
|
2809
CALL
EQT Corp
EQT
$33.9B
| $2.36M | ﹤0.01% |
44,000
-31,600
| -42% | -$1.78M |
|
2810
Piper Sandler
PIPR
$5.33B
| $2.35M | ﹤0.01% |
+27,668
| New | +$2.34M |
|
2811
Afya
AFYA
$1.27B
| $2.35M | ﹤0.01% |
152,482
-80,677
| -35% | -$1.19M |
|
2812
Euroseas
ESEA
$539M
| $2.34M | ﹤0.01% |
42,943
+6,229
| +17% | +$358K |
|
2813
Medifast
MED
$140M
| $2.34M | ﹤0.01% |
219,118
-44,530
| -17% | -$533K |
|
2814
Ollie's Bargain Outlet
OLLI
$4.37B
| $2.34M | ﹤0.01% |
21,342
+183
| +0.9% | +$22.1K |
|
2815
Penumbra
PEN
$12.7B
| $2.34M | ﹤0.01% |
7,524
-62
| -0.8% | -$17.1K |
|
2816
Buckle
BKE
$2.23B
| $2.33M | ﹤0.01% |
43,636
-24,773
| -36% | -$1.38M |
|
2817
TriMas Corp
TRS
$1.42B
| $2.33M | ﹤0.01% |
65,697
-10,615
| -14% | -$371K |
|
2818
PUT
AppFolio
APPF
$8.17B
| $2.33M | ﹤0.01% |
+10,000
| New | +$2.38M |
|
|
P
2819
Everpure Inc
P
$33B
| $2.32M | ﹤0.01% |
34,670
+11,065
| +47% | +$924K |
|
2820
CALL
Biogen
BIIB
$32.8B
| $2.32M | ﹤0.01% |
13,200
-19,300
| -59% | -$3.15M |
|
2821
Peapack-Gladstone Financial
PGC
$799M
| $2.32M | ﹤0.01% |
83,204
+17,324
| +26% | +$472K |
|
|
ORKA
2822
Oruka Therapeutics
ORKA
$6.54B
| $2.32M | ﹤0.01% |
76,415
-19,002
| -20% | -$529K |
|
2823
CALL
HF Sinclair
DINO
$17.1B
| $2.31M | ﹤0.01% |
50,200
-4,900
| -9% | -$253K |
|
2824
Huron Consulting
HURN
$2.52B
| $2.31M | ﹤0.01% |
13,341
-1,116
| -8% | -$183K |
|
2825
iShares US Medical Devices ETF
IHI
$3.4B
| $2.31M | ﹤0.01% |
37,101
-29,083
| -44% | -$1.8M |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 39% a quarter earlier, followed by Technology and Consumer Discretionary.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.